SCHEMBL1636628

SCHEMBL1636628

CCCCC(CC)C(=O)NC(CCC(=O)O)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.53
MAPK1 P28482 2/20 0.53
CA1 P00915 3/20 0.53
FOLH1 Q04609 6/20 0.51
NAALAD2 Q9Y3Q0 2/20 0.51
RIMKLA Q8IXN7 1/20 0.51
NOD1 Q9Y239 1/20 0.48
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BMP1 P13497 1/20 0.44
PLA2G2C Q5R387 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619960 1.00 CA2 (0.53) CA2MAPK1CA1FOLH1NAALAD2
SCHEMBL6413427 1.00 CA2 (0.53) CA2MAPK1CA1FOLH1NAALAD2
SCHEMBL6413425 1.00 CA2 (0.53) CA2MAPK1CA1FOLH1NAALAD2
SCHEMBL936053 0.89 NOD1 (0.54) FOLH1NAALAD2RIMKLANOD1PLA2G2C
SCHEMBL27625153 0.89 FOLH1 (0.60) FOLH1NAALAD2RIMKLABMP1
SCHEMBL26352059 0.88 FOLH1 (0.57) CA2CA1FOLH1NAALAD2RIMKLA
SCHEMBL9981032 0.88 NOD1 (0.55) FOLH1NAALAD2RIMKLANOD1
SCHEMBL29849120 0.85 USP2 (0.50) CA2MAPK1CA1BMP1PLA2G2C
SCHEMBL16240658 0.84 LMNA (0.56) CA2CA1MEN1KMT2A
SCHEMBL16240312 0.84 TDP1 (0.47) CA2MAPK1CA1BMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043460-A1 ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2025-03-06 WO claimed
WO-2025043460-A1 ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS L'OREAL (FR) 2025-03-06 WO disclosed
WO-2017108722-A1 TRIGGERED RELEASE MICROCAPSULE UNILEVER PLC (GB) 2017-06-29 WO disclosed
US-7931698-B2 Ready-to-use composition for oxidation dyeing of keratin fibers comprising at least one fatty substance, at least one thickener, at least one dye precursor, at least one oxidizing agent, and at least one alkaline agent, and process and kits therewith L'OREAL S.A. (FR) 2011-04-26 US disclosed
US-20100154140-A1 READY-TO-USE COMPOSITION FOR OXIDATION DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE THICKENER, AT LEAST ONE DYE PRECURSOR, AT LEAST ONE OXIDIZING AGENT, AND AT LEAST ONE ALKALINE AGENT, AND PROCESS AND KITS THEREWITH L'OREAL S.A. (FR) 2010-06-24 US disclosed
US-7244419-B2 A trialkyltriamide of an aspartic or glutamic acid residue; oil-based cosmetics with improved gellation, strength and transparency AJINOMOTO CO., INC. (JP) 2007-07-17 US disclosed
US-20060078581-A1 Oily gel composition AJINOMOTO CO., INC. (JP) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100154140-A1 READY-TO-USE COMPOSITION FOR OXIDATION DYEING OF KERATIN FIBERS COMPRISING AT LEAST ONE FATTY SUBSTANCE, AT LEAST ONE THICKENER, AT LEAST ONE DYE PRECURSOR, AT LEAST ONE OXIDIZING AGENT, AND AT LEAST ONE ALKALINE AGENT, AND PROCESS AND KITS THEREWITH KRT18, OAT, CKMT1A; CKMT1B CA2 2056/4885MAPK1 1855/4885CA1 1400/4885
US-20060078581-A1 Oily gel composition DGKG, DGKA, DGKK CA2 2126/4885MAPK1 3216/4885CA1 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.